Part III: From January 2013 to January 2019, a retrospective analysis was made of 73 liver transplantation patients ("bridging group") who received TACE "bridging" therapy in our hospital, of which 29 patients received TACE "bridging" therapy and 44 patients received DEB-TACE "bridging" therapy, which was the same as the aforementioned cohort. Follow-up to January 2022, the follow-up period was 3 years.
正在翻译中..